Erben Young, Li Yupeng, Da Rocha-Franco Joao A, Tawk Rabih G, Barrett Kevin M, Freeman William D, Lin Michelle, Huang Josephine F, Miller David, Farres Houssam, Brott Thomas G, Meschia James F, Hakaim Albert G
Division of Vascular and Endovascular Surgery, Mayo Clinic, Jacksonville, Florida.
Department of Political Science and Economics, Rowan University, Glassboro, New Jersey.
Int J Angiol. 2020 Sep 16;33(1):36-45. doi: 10.1055/s-0040-1712506. eCollection 2024 Feb.
The study aims to review the sex differences with respect to transient ischemic attack (TIA)/stroke and death in the perioperative period and on long-term follow-up among asymptomatic patients treated with carotid stenting (CAS) in the vascular quality initiative (VQI). All cases reported to VQI of asymptomatic CAS (ACAS) patients were reviewed. The primary end point was risk of TIA/stroke and death in the in-hospital perioperative period and in the long-term follow-up. The secondary end point was to evaluate predictors of in-hospital perioperative TIA/stroke and mortality on long-term follow-up after CAS. There were 22,079 CAS procedures captured from January 2005 to April 2019. There were 5,785 (62.7%) patients in the ACAS group. The rate of in-hospital TIA/stroke was higher in female patients (2.7 vs. 1.87%, = 0.005) and the rate of death was not significant (0.03 vs. 0.07%, = 0.66). On multivariable logistic regression analysis, prior/current smoking history (odds ratio = 0.58 [95% confidence interval or CI = 0.39-0.87]; = 0.008) is a predictor of in-hospital TIA/stroke in females. The long-term all-cause mortality is significantly higher in male patients (26.9 vs. 15.7%, < 0.001). On multivariable Cox-regression analysis, prior/current smoking history (hazard ratio or HR = 1.17 [95% CI = 1.01-1.34]; = 0.03), coronary artery disease or CAD (HR = 1.15 [95% CI = 1.03-1.28]; = 0.009), chronic obstructive pulmonary disease or COPD (HR = 1.73 [95% CI = 1.55-1.93]; < 0.001), threat to life American Society of Anesthesiologists (ASA) class (HR = 2.3 [95% CI = 1.43-3.70]; = 0.0006), moribund ASA class (HR = 5.66 [95% CI = 2.24-14.29]; = 0.0003), and low hemoglobin levels (HR = 0.84 [95% CI = 0.82-0.86]; < 0.001) are the predictors of long-term mortality. In asymptomatic carotid disease patients, women had higher rates of in-hospital perioperative TIA/stroke and a predictor of TIA/stroke is a prior/current history of smoking. Meanwhile, long-term all-cause mortality is higher for male patients compared with their female counterparts. Predictors of long-term mortality are prior/current smoking history, CAD, COPD, higher ASA classification of physical status, and low hemoglobin level. These data should be considered prior to offering CAS to asymptomatic female and male patients and careful risks versus benefits discussion should be offered to each individual patient.
本研究旨在回顾血管质量倡议(VQI)中接受颈动脉支架置入术(CAS)治疗的无症状患者围手术期及长期随访中短暂性脑缺血发作(TIA)/中风和死亡方面的性别差异。对所有向VQI报告的无症状CAS(ACAS)患者病例进行了回顾。主要终点是围手术期住院期间及长期随访中TIA/中风和死亡的风险。次要终点是评估CAS术后围手术期住院期间TIA/中风及长期随访中死亡率的预测因素。2005年1月至2019年4月共记录了22,079例CAS手术。ACAS组有5,785例患者(62.7%)。女性患者围手术期住院期间TIA/中风发生率更高(2.7%对1.87%,P = 0.005),而死亡率无显著差异(0.03%对0.07%,P = 0.66)。多变量逻辑回归分析显示,既往/当前吸烟史(比值比 = 0.58 [95%置信区间或CI = 0.39 - 0.87];P = 0.008)是女性围手术期住院期间TIA/中风的预测因素。男性患者长期全因死亡率显著更高(26.9%对15.7%,P < 0.001)。多变量Cox回归分析显示,既往/当前吸烟史(风险比或HR = 1.17 [95% CI = 1.01 - 1.34];P = 0.03)、冠状动脉疾病或CAD(HR = 1.15 [95% CI = 1.03 - 1.28];P = 0.009)、慢性阻塞性肺疾病或COPD(HR = 1.73 [95% CI = 1.55 - 1.93];P < 0.001)、美国麻醉医师协会(ASA)生命威胁分级(HR = 2.3 [95% CI = 1.43 - 3.70];P = 0.0006)、濒死ASA分级(HR = 5.66 [95% CI = 2.24 - 14.29];P = 0.0003)及低血红蛋白水平(HR = 0.84 [95% CI = 0.82 - 0.86];P < 0.001)是长期死亡率的预测因素。在无症状颈动脉疾病患者中,女性围手术期住院期间TIA/中风发生率更高,TIA/中风的一个预测因素是既往/当前吸烟史。同时,男性患者长期全因死亡率高于女性。长期死亡率的预测因素包括既往/当前吸烟史、CAD、COPD、更高的ASA身体状况分级及低血红蛋白水平。在为无症状女性和男性患者提供CAS治疗前应考虑这些数据,并应与每位患者仔细讨论风险与获益。